Showing 251-260 of 7710 results for "".
Allergan's Cool Campaign, Obagi Line Launches, Apple Upgrades Health App
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-allergan-s-cool-campaign-obagi-line-launches-apple-upgrades-health-app/18346/There's some misleading information about fat reduction out there, and that's not cool, Allergan says. The company's CoolSculpting device has launched the “Not Cool Vs. Cool” campaign. Data show patients and doctors assess scars differently: Patients tend to focus on scar depth, while physicians focThe Year in Aesthetics
https://practicaldermatology.com/topics/practice-management/the-year-in-aesthetics/20399/A look at innovations and approvals in cosmetic dermatology in 2017.Janssen Approvals, New Thermage FLX, Restylane Silk Cannulas
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-janssen-approvals-new-thermage-flx-restylane-silk-cannulas/18401/Janssen Biotech's Stelara is now approved for the treatment of adolescents 12 years of age or older with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Janssen's SIMPONI ARIA® cleared for the treatment of adults with active psoriatic arthritis or activeOf Mips and Tucks: Making Sense of the Latest Serving of CMS' Alphabet Soup
https://practicaldermatology.com/topics/practice-management/of-mips-and-tucks-making-sense-of-the-latest-serving-of-cms-alphabet-soup/20989/Get your acronyms in order with this handy guide.Long-Term Effects of Neuromodulators on Aging
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/long-term-effects-of-neuromodulators-on-aging/18810/Shannon Humphrey, MD discusses the cumulative anti-aging benefits of long-term treatments with botulinum toxin type A. She shares her observations from the bench and offers a review of what the literature shows to support her recommendation for regular conservative neuromodulator treatments to improThe Art of Medicine in the Age of Technology
https://practicaldermatology.com/topics/practice-management/the-art-of-medicine-in-the-age-of-technology/21065/Although electronic technology offers potential for a more efficient delivery of healthcare, the patient experience may suffer as a result.Valeant Business Update; Melanoma Drugs Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-valeant-business-update-melanoma-drugs-approved/18679/In this edition of DermWireTV from the editors of Practical Dermatology® magazine and DermWire.com, we take a look at Valeant's warning of disruption of dermatology business following its break from specialty pharmacy Philidor. Plus, an update on Melanoma Therapeutics, including approvals of ImlygicSummer AAD Highlights, Alopecia Areata Discovery
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-summer-aad-highlights-alopecia-areata-discovery/18846/In this edition of DermWireTV from the editors of Practical Dermatology® magazine and DermWire.com, new research that suggests emerging biologic therapies could help treat alopecia areata. Plus, updates on atopic dermatitis and eczema, hands-on education, and Kybella from the AAD Summer meeting. AndAging: The Cornerstone of Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/aging-the-cornerstone-of-dermatology/18865/In this edition of Derm Insider, Joseph Jorizzo, MD, Brooke Jackson, MD, and Adam Friedman, MD sit down with host Neal Bhatia, MD to discuss the phenomenon of aging and the ubiquitous role it plays in both the scientific and clinical practice of dermatology. In particular they reflect on the evolutiEpiduo Forte Approved; Facial Aesthetics By Age
https://practicaldermatology.com/topics/practice-management/dermwiretv-epiduo-forte-approved-facial-aesthetics-by-age/18870/Galderma's non-antibiotic Epiduo Forte (Adapalene 0.3% and benzoyl peroxide 2.5%) approved for topical management of acne vulgaris. Trends reveal differences in women's facial cosmetic surgery by age. AMA and CMS offer ICD-10 help. Plus: An Update on NewDerm LIVE.